GZMK and acute myeloid leukemia: We thus investigated whether GZMK expression correlated with outcomes and found that AML patients in the TCGA cohort53 with higher GZMK (p = 0.0017) expression had improved overall survival, suggesting that inherent immunity with elevated GZMK can elicit improved outcomes in AML (Fig. 3H).